semaglutide for bariatric patients induces weight loss nonresponders to surgery Semaglutide vs Bariatric Surgery: Weight

Adults taking the 2.4 mg weekly injection, combined with lifestyle intervention, typically lost an average of 15% to 17% of their body weight over approximately 68 weeks

NEJM Rosenstock, J., et al

A novel role for a glycosylphosphatidylinositol-anchored aspartyl protease, CgYps1, in the regulation of pH homeostasis in Candida glabrata

Each has a different mechanism, a different depth (epidermal, dermal or mixed), a different trigger and a fundamentally different treatment requirement

Understanding Semaglutide: A GLP-1 Receptor Agonist Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist (a medication that mimics a natural hormone regulating blood sugar and appetite)